Clinical Trial Update: A Therapeutic Equivalence Study of Ketoconazole Cream 2% [Phase 3]

View source ↗

Summary

Phase 3 therapeutic equivalence trial of Ketoconazole Cream 2% for tinea pedis completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinea Pedis

Drugs mentioned

• Ketoconazole cream, 2% (ketoconazole)

Snippet

Sponsor: Douglas Pharmaceuticals America Ltd | Conditions: Tinea Pedis | Phase 3 | Status: COMPLETED